Anfahrt    Babygalerie    

Akademisches Lehrkrankenhaus der Johannes Gutenberg-Universität Mainz

Druckersymbol  

Publikationen

 

Publikationen

PubMed - NCBI

Results: 17

  1. Expression of mutated isocitrate dehydrogenase-1 in gliomas is associated with p53 and EGFR expression.
    Birner P, Toumangelova-Uzeir K, Natchev S, Guentchev M.
    Folia Neuropathol. 2011;49(2):88-93.
    PMID: 21845536 [PubMed - in process]

  2. Additive effect on survival of Raf kinase inhibitor protein and signal transducer and activator of transcription 3 in high-grade glioma.
    Maresch J, Birner P, Zakharinov M, Toumangelova-Uzeir K, Natchev S, Guentchev M.
    Cancer. 2010 Dec 14. [Epub ahead of print]
    PMID: 21157951 [PubMed - as supplied by publisher]

  3. STAT3 tyrosine phosphorylation influences survival in glioblastoma.
    Birner P, Toumangelova-Uzeir K, Natchev S, Guentchev M.
    J Neurooncol. 2010 Dec;100(3):339-43. Epub 2010 May 9.
    PMID: 20455003 [PubMed - indexed for MEDLINE]

  4. The role of parvalbumin and calbindin D28k in experimental scrapie.
    Voigtländer T, Unterberger U, Guentchev M, Schwaller B, Celio MR, Meyer M, Budka H.
    Neuropathol Appl Neurobiol. 2008 Aug;34(4):435-45. Epub 2007 Nov 25.
    PMID: 18005331 [PubMed - indexed for MEDLINE]

  5. Notch controls proliferation and differentiation of stem cells in a dose-dependent manner.
    Guentchev M, McKay RD. Eur J Neurosci. 2006 May;23(9):2289-96. Erratum in: Eur J Neurosci. 2006 Sep;24(5):1504.
    PMID: 16706837 [PubMed - indexed for MEDLINE]

  6. Redox metals and oxidative abnormalities in human prion diseases. Petersen RB, Siedlak SL, Lee HG, Kim YS, Nunomura A, Tagliavini F, Ghetti B, Cras P, Moreira PI, Castellani RJ, Guentchev M, Budka H, Ironside JW, Gambetti P, Smith MA, Perry G.
    Acta Neuropathol. 2005 Sep;110(3):232-8. Epub 2005 Aug 11.
    PMID: 16096758 [PubMed - indexed for MEDLINE]

  7. Complement activation in human prion disease.
    Kovacs GG, Gasque P, Ströbel T, Lindeck-Pozza E, Strohschneider M, Ironside JW, Budka H, Guentchev M.
    Neurobiol Dis. 2004 Feb;15(1):21-8.
    PMID: 14751767 [PubMed - indexed for MEDLINE]

  8. Oxidative damage to nucleic acids in human prion disease.
    Guentchev M, Siedlak SL, Jarius C, Tagliavini F, Castellani RJ, Perry G, Smith MA, Budka H.
    Neurobiol Dis. 2002 Apr;9(3):275-81.
    PMID: 11950273 [PubMed - indexed for MEDLINE]

  9. Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases.
    Voigtländer T, Klöppel S, Birner P, Jarius C, Flicker H, Verghese-Nikolakaki S, Sklaviadis T, Guentchev M, Budka H.
    Acta Neuropathol. 2001 May;101(5):417-23.
    PMID: 11484812 [PubMed - indexed for MEDLINE]

  10. Serotonergic nuclei of the raphe are not affected in human ageing.
    Klöppel S, Kovacs GG, Voigtländer T, Wanschitz J, Flicker H, Hainfellner JA, Guentchev M, Budka H.
    Neuroreport. 2001 Mar 26;12(4):669-71.
    PMID: 11277560 [PubMed - indexed for MEDLINE]

  11. Alteration of the serotonergic nervous system in fatal familial insomnia.
    Wanschitz J, Klöppel S, Jarius C, Birner P, Flicker H, Hainfellner JA, Gambetti P, Guentchev M, Budka H.
    Ann Neurol. 2000 Nov;48(5):788-91.
    PMID: 11079543 [PubMed - indexed for MEDLINE]

  12. Evidence for oxidative stress in experimental prion disease.
    Guentchev M, Voigtländer T, Haberler C, Groschup MH, Budka H.Neurobiol Dis.
    2000 Aug;7(4):270-3.
    PMID: 10964599 [PubMed - indexed for MEDLINE]

  13. Selective neuronal vulnerability in human prion diseases.
    Fatal familial insomnia differs from other types of prion diseases.
    Guentchev M, Wanschitz J, Voigtländer T, Flicker H, Budka H.
    Am J Pathol. 1999 Nov;155(5):1453-7.
    PMID: 10550300 [PubMed - indexed for MEDLINE]

  14. Severe, early and selective loss of a subpopulation of GABAergic inhibitory neurons in experimental transmissible spongiform encephalopathies.
    Guentchev M, Groschup MH, Kordek R, Liberski PP, Budka H.
    Brain Pathol. 1998 Oct;8(4):615-23.
    PMID: 9804371 [PubMed - indexed for MEDLINE]

  15. Distribution of parvalbumin-immunoreactive neurons in brain correlates with hippocampal and temporal cortical pathology in Creutzfeldt-Jakob disease.
    Guentchev M, Hainfellner JA, Trabattoni GR, Budka H.
    J Neuropathol Exp Neurol. 1997 Oct;56(10):1119-24.
    PMID: 9329455 [PubMed - indexed for MEDLINE]

  16. [Creutzfeldt-Jakob disease in Austria].
    Hainfellner JA, Jellinger K, Diringer H, Guentchev M, Kleinert R, Pilz P, Maier H, Budka H.
    Wien Klin Wochenschr. 1996 Dec 13;108(23):759-63. German.
    PMID: 9092208 [PubMed - indexed for MEDLINE]

  17. Creutzfeldt-Jakob disease in Austria.
    Hainfellner JA, Jellinger K, Diringer H, Guentchev M, Kleinert R, Pilz P, Maier H, Budka H.
    J Neurol Neurosurg Psychiatry. 1996 Aug;61(2):139-42.
    PMID: 8708680 [PubMed - indexed for MEDLINE]